The procedure involves drawing blood, treating it with a laser and ozone, and then reentering it into the body but is not FDA ...

Building FDA submissions like a solid house requires early collaboration, proactive planning, and a clear regulatory story.

CAAR ruled that multi-functional PCR instruments cannot be treated as spectrometers where optical detection is only one part ...